Accelerated drug discovery with AI
Raminderpal Singh is the Founder and CEO of Incubate Bio (London, UK), a company working to develop in silico data packages containing important target and biomarker models for the biotech and biopharma spheres. With a background in computation, Singh is interested in how AI can be implemented in the drug discovery field and what this actually means for science. In this interview from ELRIG Drug Discovery 2023 (18–19 October 2023; Liverpool, UK), Content Editor Aisha Al-Janabi spoke with Singh about the importance of a systems approach to science, data and the use of AI as well as Singh’s passion for...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
